Independent Director · Bicara Therapeutics Inc. (BCAX)

Nils Lonberg director compensation at Bicara Therapeutics: $257K

Fiscal year 2025 director compensation for Nils Lonberg at Bicara Therapeutics Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 27, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Nils Lonberg’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Nils Lonberg and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Bicara Therapeutics Director Compensation Table · the one fiscal year held
In US dollars, as Bicara Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$48,000—$208,634—$256,634

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Bicara Therapeutics Inc. DEF 14A filed April 27, 2026, accession 0001628280-26-027320, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Bicara Therapeutics Inc. filed document, accession 0001628280-26-027320. Every figure is read from that document and cited to the page and table it appears in. Filed April 27, 2026.

Get the Bicara Therapeutics Board Governance Report

$256,634 Nils Lonberg, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 27, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Bicara Therapeutics pays directors a $40,000 cash retainer and $47,492 in Options.

The rest of the Bicara Therapeutics board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Carolyn NgIndependent Director$0
Christopher BowdenIndependent Director$253,634
Jake SimsonIndependent Director$252,634
Kate HavilandIndependent Director$253,634
Kiran Mazumdar-ShawIndependent Director$252,634
Michael PowellIndependent Director$296,134
Scott RobertsonIndependent Director$263,634

The full Bicara Therapeutics compensation record

free company brief

This page is one director within Bicara Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Order BCAX

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report